Inovio pharmaceuticals, inc. reports earnings results for the third quarter ended september 30, 2019

Inovio pharmaceuticals, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced total revenue was usd 866,863 compared to usd 2.000 million a year ago. operating loss was usd 23.951 million compared to usd 26.642 million a year ago. net loss was usd 23.090 million compared to usd 25.015 million a year ago. basic loss per share was usd 0.23 compared to usd 0.27 a year ago. diluted loss per share was usd 0.25 compared to usd 0.27 a year ago. for the nine months, total revenue was usd 3.832 million compared to usd 27.979 million a year ago. operating loss was usd 80.687 million compared to usd 64.591 million a year ago. net loss was usd 81.697 million compared to usd 64.005 million a year ago. basic loss per share was usd 0.83 compared to usd 0.7 a year ago.
INO Ratings Summary
INO Quant Ranking